• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性炎症性疾病中冠心病发病的比较风险

Comparative Risk of Incident Coronary Heart Disease Across Chronic Inflammatory Diseases.

作者信息

Sinha Arjun, Rivera Adovich S, Chadha Simran A, Prasada Sameer, Pawlowski Anna E, Thorp Edward, DeBerge Matthew, Ramsey-Goldman Rosalind, Lee Yvonne C, Achenbach Chad J, Lloyd-Jones Donald M, Feinstein Matthew J

机构信息

Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.

Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.

出版信息

Front Cardiovasc Med. 2021 Nov 10;8:757738. doi: 10.3389/fcvm.2021.757738. eCollection 2021.

DOI:10.3389/fcvm.2021.757738
PMID:34859072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8631433/
Abstract

Chronic inflammatory diseases (CIDs) are considered risk enhancing factors for coronary heart disease (CHD). However, sparse data exist regarding relative CHD risks across CIDs. Determine relative differences in CHD risk across multiple CIDs: psoriasis, rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), human immunodeficiency virus (HIV), systemic sclerosis (SSc), and inflammatory bowel disease (IBD). The cohort included patients with CIDs and controls without CID in an urban medical system from 2000 to 2019. Patients with CIDs were frequency-matched with non-CID controls on demographics, hypertension, and diabetes. CHD was defined as myocardial infarction (MI), ischemic heart disease, and/or coronary revascularization based on validated administrative codes. Multivariable-adjusted Cox models were used to determine the risk of incident CHD and MI for each CID relative to non-CID controls. In secondary analyses, we compared CHD risk by disease severity within each CID. Of 17,049 patients included for analysis, 619 had incident CHD (202 MI) over an average of 4.4 years of follow-up. The multivariable-adjusted risk of CHD was significantly higher for SLE [hazard ratio (HR) 1.9, 95% confidence interval (CI) 1.2, 3.2] and SSc (HR 2.1, 95% CI 1.2, 3.9). Patients with SLE also had a significantly higher risk of MI (HR 3.6, 95% CI 1.9, 6.8). When CIDs were categorized by markers of disease severity (C-reactive protein for all CIDs except HIV, for which CD4 T cell count was used), greater disease severity was associated with higher CHD risk across CIDs. Patients with SLE and SSc have a higher risk of CHD. CHD risk with HIV, RA, psoriasis, and IBD may only be elevated in those with greater disease severity. Clinicians should personalize CHD risk and treatment based on type and severity of CID.

摘要

慢性炎症性疾病(CIDs)被认为是冠心病(CHD)的风险增强因素。然而,关于不同CIDs相对CHD风险的数据却很稀少。确定多种CIDs(银屑病、类风湿性关节炎(RA)、系统性红斑狼疮(SLE)、人类免疫缺陷病毒(HIV)、系统性硬化症(SSc)和炎症性肠病(IBD))之间CHD风险的相对差异。该队列包括2000年至2019年期间城市医疗系统中患有CIDs的患者和未患CIDs的对照。患有CIDs的患者在人口统计学、高血压和糖尿病方面与非CIDs对照进行频率匹配。CHD根据经过验证的行政代码定义为心肌梗死(MI)、缺血性心脏病和/或冠状动脉血运重建。使用多变量调整的Cox模型确定每种CIDs相对于非CIDs对照发生CHD和MI的风险。在二次分析中,我们比较了每种CIDs内疾病严重程度的CHD风险。在纳入分析的17049名患者中,平均4.4年的随访期间有619人发生CHD(202例MI)。SLE [风险比(HR)1.9,95%置信区间(CI)1.2,3.2]和SSc(HR 2.1,95%CI 1.2,3.9)的多变量调整CHD风险显著更高。SLE患者发生MI的风险也显著更高(HR 3.6,95%CI 1.9,6.8)。当根据疾病严重程度标志物对CIDs进行分类时(除HIV外所有CIDs使用C反应蛋白,HIV使用CD4 T细胞计数),在所有CIDs中,疾病严重程度越高,CHD风险越高。SLE和SSc患者患CHD的风险更高。HIV、RA、银屑病和IBD的CHD风险可能仅在疾病严重程度较高的患者中升高。临床医生应根据CIDs的类型和严重程度对CHD风险和治疗进行个性化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/823f/8631433/7ded4f32bd89/fcvm-08-757738-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/823f/8631433/df0d332a1e66/fcvm-08-757738-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/823f/8631433/68a065687800/fcvm-08-757738-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/823f/8631433/f9f20a77a605/fcvm-08-757738-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/823f/8631433/7ded4f32bd89/fcvm-08-757738-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/823f/8631433/df0d332a1e66/fcvm-08-757738-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/823f/8631433/68a065687800/fcvm-08-757738-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/823f/8631433/f9f20a77a605/fcvm-08-757738-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/823f/8631433/7ded4f32bd89/fcvm-08-757738-g0004.jpg

相似文献

1
Comparative Risk of Incident Coronary Heart Disease Across Chronic Inflammatory Diseases.慢性炎症性疾病中冠心病发病的比较风险
Front Cardiovasc Med. 2021 Nov 10;8:757738. doi: 10.3389/fcvm.2021.757738. eCollection 2021.
2
Differential Associations of Chronic Inflammatory Diseases With Incident Heart Failure.慢性炎症性疾病与心力衰竭事件的相关性差异。
JACC Heart Fail. 2020 Jun;8(6):489-498. doi: 10.1016/j.jchf.2019.11.013. Epub 2020 Apr 8.
3
Phenotypic Presentations of Heart Failure Among Patients With Chronic Inflammatory Diseases.慢性炎症性疾病患者心力衰竭的表型表现
Front Cardiovasc Med. 2022 Mar 16;9:784601. doi: 10.3389/fcvm.2022.784601. eCollection 2022.
4
Long-Term Trajectories of Left Ventricular Ejection Fraction in Patients With Chronic Inflammatory Diseases and Heart Failure: An Analysis of Electronic Health Records.慢性炎症性疾病合并心力衰竭患者左心室射血分数的长期变化:电子健康记录分析。
Circ Heart Fail. 2021 Aug;14(8):e008478. doi: 10.1161/CIRCHEARTFAILURE.121.008478. Epub 2021 Aug 10.
5
Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.类风湿关节炎患者中未被识别的冠心病和猝死增加:一项基于人群的队列研究。
Arthritis Rheum. 2005 Feb;52(2):402-11. doi: 10.1002/art.20853.
6
Healthcare resource utilization and costs associated with inflammatory bowel disease among patients with chronic inflammatory diseases: a retrospective cohort study.慢性炎症性疾病患者中炎症性肠病的医疗资源利用及成本:一项回顾性队列研究。
BMC Rheumatol. 2020 Apr 2;4:16. doi: 10.1186/s41927-020-0115-2. eCollection 2020.
7
Real-world incidence of inflammatory bowel disease among patients with other chronic inflammatory diseases treated with interleukin-17a or phosphodiesterase 4 inhibitors.在接受白细胞介素-17A 或磷酸二酯酶 4 抑制剂治疗的其他慢性炎症性疾病患者中,炎症性肠病的真实世界发病率。
Curr Med Res Opin. 2019 Oct;35(10):1751-1759. doi: 10.1080/03007995.2019.1620713. Epub 2019 Jun 6.
8
Association of Sickle Cell Trait With Incidence of Coronary Heart Disease Among African American Individuals.镰状细胞特征与非裔美国人冠心病发病率的关联。
JAMA Netw Open. 2021 Jan 4;4(1):e2030435. doi: 10.1001/jamanetworkopen.2020.30435.
9
Chronic Inflammatory Diseases - Diabetes Mellitus, Rheumatoid Arthritis, Coeliac Disease, Crohn's Disease, and Ulcerative Colitis Among the Offspring of Affected Parents: A Danish Population-Based Registry Study.慢性炎症性疾病——受影响父母的后代中的糖尿病、类风湿性关节炎、乳糜泻、克罗恩病和溃疡性结肠炎:一项基于丹麦人群登记处的研究
Clin Epidemiol. 2021 Jan 7;13:13-20. doi: 10.2147/CLEP.S286623. eCollection 2021.
10
Immune-mediated inflammatory diseases and the risk of valvular heart disease: a Mendelian randomization study.免疫介导的炎症性疾病与心脏瓣膜病风险:一项孟德尔随机研究。
Clin Rheumatol. 2024 Jan;43(1):533-541. doi: 10.1007/s10067-023-06693-7. Epub 2023 Jul 28.

引用本文的文献

1
Overview of Oxidative Stress in Systemic Lupus Erythematosus.系统性红斑狼疮中的氧化应激概述
Antioxidants (Basel). 2025 Mar 1;14(3):303. doi: 10.3390/antiox14030303.
2
Microvascular Density Analysis of Patients with Inactive Systemic Lupus Erythematosus-A Two-Year Follow-Up Optical Coherence Tomography Angiography Study.非活动期系统性红斑狼疮患者的微血管密度分析——一项为期两年的光学相干断层扫描血管造影随访研究
J Clin Med. 2024 May 18;13(10):2979. doi: 10.3390/jcm13102979.
3
Risk of diabetes mellitus in systemic lupus erythematosus: systematic review and meta-analysis.

本文引用的文献

1
Colchicine in Patients with Chronic Coronary Disease.秋水仙碱治疗慢性冠心病
N Engl J Med. 2020 Nov 5;383(19):1838-1847. doi: 10.1056/NEJMoa2021372. Epub 2020 Aug 31.
2
Differential Associations of Chronic Inflammatory Diseases With Incident Heart Failure.慢性炎症性疾病与心力衰竭事件的相关性差异。
JACC Heart Fail. 2020 Jun;8(6):489-498. doi: 10.1016/j.jchf.2019.11.013. Epub 2020 Apr 8.
3
From CANTOS to CIRT to COLCOT to Clinic: Will All Atherosclerosis Patients Soon Be Treated With Combination Lipid-Lowering and Inflammation-Inhibiting Agents?
系统性红斑狼疮患者患糖尿病的风险:系统评价与荟萃分析。
Rheumatology (Oxford). 2024 Aug 1;63(8):2047-2055. doi: 10.1093/rheumatology/keae204.
4
Inflammatory bowel disease patients have an increased risk of acute coronary syndrome: a systematic review and meta-analysis.炎症性肠病患者发生急性冠状动脉综合征的风险增加:系统评价和荟萃分析。
Open Heart. 2023 Nov;10(2). doi: 10.1136/openhrt-2023-002483.
5
Crohn's disease in human immunodeficiency virus-infected patient: A case report.人类免疫缺陷病毒感染患者的克罗恩病:一例报告。
World J Clin Cases. 2023 Jun 16;11(17):4202-4209. doi: 10.12998/wjcc.v11.i17.4202.
6
Phenotypic Presentations of Heart Failure Among Patients With Chronic Inflammatory Diseases.慢性炎症性疾病患者心力衰竭的表型表现
Front Cardiovasc Med. 2022 Mar 16;9:784601. doi: 10.3389/fcvm.2022.784601. eCollection 2022.
从CANTOS研究到CIRT研究再到COLCOT研究,直至临床应用:所有动脉粥样硬化患者很快都将接受降脂与抗炎联合治疗吗?
Circulation. 2020 Mar 10;141(10):787-789. doi: 10.1161/CIRCULATIONAHA.119.045256. Epub 2020 Mar 9.
4
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.心梗后小剂量秋水仙碱的疗效和安全性。
N Engl J Med. 2019 Dec 26;381(26):2497-2505. doi: 10.1056/NEJMoa1912388. Epub 2019 Nov 16.
5
Cardiovascular Manifestations of Systemic Sclerosis: A Danish Nationwide Cohort Study.系统性硬化症的心血管表现:一项丹麦全国队列研究。
J Am Heart Assoc. 2019 Sep 3;8(17):e013405. doi: 10.1161/JAHA.119.013405. Epub 2019 Aug 24.
6
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2019美国心脏病学会/美国心脏协会心血管疾病一级预防指南:美国心脏病学会/美国心脏协会临床实践指南工作组报告
J Am Coll Cardiol. 2019 Sep 10;74(10):e177-e232. doi: 10.1016/j.jacc.2019.03.010. Epub 2019 Mar 17.
7
Adjudicated Heart Failure in HIV-Infected and Uninfected Men and Women.经裁定的 HIV 感染和未感染男性和女性的心衰。
J Am Heart Assoc. 2018 Nov 6;7(21):e009985. doi: 10.1161/JAHA.118.009985.
8
Validation of a claims-based algorithm identifying eligible study subjects in the ADAPTABLE pragmatic clinical trial.在ADAPTABLE实用临床试验中,基于索赔的算法用于识别合格研究对象的验证。
Contemp Clin Trials Commun. 2018 Nov 10;12:154-160. doi: 10.1016/j.conctc.2018.11.001. eCollection 2018 Dec.
9
Inflammatory bowel disease and cardiovascular disease incidence and mortality: A meta-analysis.炎症性肠病与心血管疾病的发病和死亡:荟萃分析。
Eur J Prev Cardiol. 2018 Oct;25(15):1623-1631. doi: 10.1177/2047487318792952. Epub 2018 Aug 3.
10
Surgical Rates for Crohn's Disease are Decreasing: A Population-Based Time Trend Analysis and Validation Study.克罗恩病的手术率正在下降:一项基于人群的时间趋势分析与验证研究
Am J Gastroenterol. 2017 Dec;112(12):1840-1848. doi: 10.1038/ajg.2017.394. Epub 2017 Oct 31.